{
  "orphacode": "272",
  "disease_name": "Congenital muscular dystrophy, Fukuyama type",
  "socioeconomic_impact_studies": [
    {
      "cost": 0,
      "measure": "",
      "label": "Congenital Muscular Dystrophies and Congenital Myopathies",
      "source": "https://pubmed.ncbi.nlm.nih.gov/24305446/",
      "country": "USA",
      "year": "2013"
    },
    {
      "cost": 0,
      "measure": "",
      "label": "Distrofia muscular congénita tipo Fukuyama",
      "source": "https://www.orpha.net/es/disease/detail/272",
      "country": "International",
      "year": "2023"
    }
  ],
  "score": 3,
  "evidence_level": "Low evidence",
  "justification": "No cost-of-illness or quantitative economic data specific to FCMD were identified. Clinical reviews and Orphanet entries document severe disability, epilepsy, and high care needs, indicating substantial qualitative burden. citeturn3view0turn1search0",
  "metadata": {
    "processing_timestamp": "2025-07-18T19:22:18.215553",
    "run_number": 1,
    "orphacode": "272"
  }
}